Description
BML-277 is an arylbenzimidazole inhibitor of checkpoint kinase 2 (CHK2). This compound displays cytoprotective activity, protecting CD4+ and CD8+ T cells against radiation-induced apoptosis.
BML-277
Product ID B5044
Cas No. 516480-79-8
Purity ≥98%
| Product Unit Size | Cost | Quantity | Stock |
|---|
Product Info
| Cas No. | 516480-79-8 |
|---|---|
| Purity | ≥98% |
| Formula | C20H14ClN3O2 |
| Formula Wt. | 363.80 |
| Chemical Name | 2-[4-(4-Chlorophenoxy)phenyl]-1H-benzimidazole-5-carboxamide |
| IUPAC Name | 2-[4-(4-Chlorophenoxy)phenyl]-1H-benzimidazole-5-carboxamide |
| Solubility | DMSO 72 mg/mL Ethanol 21 mg/mL Water Insoluble |
Shipping and Storage
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
Downloads
| MSDS | |
|---|---|
| Info Sheet |
References
Arienti KL, Brunmark A, Axe FU, et al. Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles. J Med Chem. 2005 Mar 24;48(6):1873-85. PMID: 15771432.